Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

AdvisorShares Pure US Cannabis ETF MSOS

The investment seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group within the health care sector. The fund is non-diversified.


ARCA:MSOS - Post by User

Post by Wrywisdomon Jul 15, 2022 1:26pm
66 Views
Post# 34827448

ENTG Extends Primary Credit Facility with BMO/Others 2+Years

ENTG Extends Primary Credit Facility with BMO/Others 2+YearsFor those not aware, Entourage has extended and improved it's primary credit facility with Bank of Montreal for two more years, furthering it's relationship with one of Canada's most prestigious and established financial institutions. 

It also has extended it's agreements with secondary lenders beyond two years, with the flexibility to pay only interest at the discretion of Entourage.

Add to that revenues soaring every quarter (now more than 60 million dollars over the past 4 quarters), and they are firmly positioned to implement the entirety of their extraordinariy multifaceted strategy in the recreational and medical markets;  as well as furthering their synergies with Boston Beer, Mary's Medicinals, Fire and Flower, and much more. 

https://stockhouse.com/news/press-releases/2022/07/04/entourage-health-announces-amendments-to-its-credit-facilities-to-improve-debt

ENTG Revenues  should exceed expenses by the autumn as the growth and expansion phase winds down, and the revenues from expanded production tiers soar.

Simply a stellar opportunity here.
<< Previous
Bullboard Posts
Next >>